Investment Rating - The report maintains a "Buy" rating for Xiaomi Group with a target price of HK$70.00, indicating a potential upside of 36% from the current price of HK$51.55 [3][12][18]. Core Insights - Xiaomi's 1Q25 performance exceeded expectations, with revenue and adjusted net profit reaching RMB 111.2 billion and RMB 10.6 billion, respectively, surpassing forecasts by 3% and 5% [10]. - The smartphone segment showed a 3% year-on-year sales growth, with high-end models accounting for 25% of shipments in China [10]. - The IoT segment experienced a significant revenue increase of 59% year-on-year, driven by a doubling of revenue from IoT home appliances and a 65% increase in sales volume [10]. - The electric vehicle (EV) and AI business generated RMB 18.6 billion in revenue, with a gross margin of 23.2%, higher than the forecasted 20.8% [10]. - Overall gross margin reached 22.8%, the highest since 2017, attributed to improved operational efficiency and increased investment income [10]. Financial Projections - Revenue for 2025 is projected at RMB 481.3 billion, reflecting a 32% year-on-year growth, with adjusted net profit expected to reach RMB 41.9 billion, an 82% increase [16][20]. - The report anticipates a cautious outlook for smartphone shipment growth, projecting a 3% increase in 2025, with price increases being a key growth driver [11]. - Adjusted EPS for 2025 is forecasted to be RMB 1.64, up from RMB 1.57, representing a 5% increase [4][16]. Valuation - The target P/E ratio for 2026 has been adjusted down to 28.5 times adjusted net profit, reflecting ongoing macroeconomic uncertainties [17]. - The valuation remains at an 8% premium compared to Apple's current P/E ratio, based on stronger growth prospects for Xiaomi [17][18].

Group 1 - Investment Rating: Buy with a target price of HK$70.00 [2][3][23] - Core Viewpoint: The company expects advertising revenue to recover to double-digit growth in the second half of 2025, driven mainly by external advertising [2][8][9] - Revenue and Profit Summary: In Q1 2025, revenue grew by 11% year-on-year to RMB 32.6 billion, and adjusted net profit was RMB 4.6 billion, both in line with expectations [2][3][20] Group 2 - Financial Forecasts: Revenue and adjusted net profit forecasts for 2025-2027 remain largely unchanged [21][23] - Shareholder Returns: The company announced a share buyback plan of HK$16 billion over the next 36 months, with a total of 29.2 million shares repurchased so far this year [3][21] - Key Financial Metrics: The projected revenue for 2025 is RMB 141.9 billion, with an adjusted net profit of RMB 20.4 billion, reflecting a year-on-year growth of 12% [5][21][27]

Investment Rating - The report maintains a "Hold" rating for the company with a target price slightly adjusted to RMB 90.00 from RMB 95.00 [3][15][8] Core Views - The company's revenue for 1Q25 was below expectations, but new orders signed in 2024 are expected to contribute to revenue in 2025 [2][8] - The decline in net profit growth compared to revenue growth is attributed to ongoing investments in new product research and development [1][9] - The acquisition of shares by Northern Huachuang is anticipated to positively impact the company's financial performance in the medium to long term [2][15] Summary by Sections Financial Performance - In 2024, the company reported revenue of RMB 1.75 billion, a year-on-year increase of 2.13%, with a net profit of RMB 203 million, down 19.08% year-on-year [1][10] - For 1Q25, revenue was RMB 275 million, a 12.74% increase year-on-year, but net profit fell to RMB 5 million, a 70.89% decrease year-on-year [1][10] Order and Product Development - The company signed new orders worth RMB 2.4 billion in 2024, a 10% increase year-on-year, with strong performance in various product lines including photoresist coating and developing machines [2][8] - New products such as the front-end chemical cleaning machine and physical cleaning machine have received significant orders from major domestic clients [2][8] Earnings Forecast Adjustments - The earnings per share (EPS) forecast for 2025 has been reduced by 32% to RMB 1.29 due to lower-than-expected net profit in 1Q25 and increased R&D expenses [3][11] - Revenue projections for 2025, 2026, and 2027 are expected to grow by 29%, 30%, and 24% respectively, with net profit margins improving over the years [9][11] Valuation - The current valuation is set at 69 times the 2025 P/E ratio, reflecting market expectations regarding the acquisition by Northern Huachuang and its potential benefits for revenue and profit growth [3][15] - The company is projected to achieve a net profit growth rate of 46% from 2024 to 2027, which is higher than the industry average of 37% [15][16]

Investment Rating - The report maintains a "Buy" rating for Xiaomi Group with a target price of HK$70.00, indicating a potential upside of approximately 40% from the current price of HK$50.10 [2][7][12]. Core Insights - The report highlights that operational leverage will be a key highlight for Xiaomi in the upcoming quarters, particularly driven by strong growth in the IoT segment and strategic adjustments in the smartphone market [3][4]. - The anticipated strong performance in Q1 2025 is attributed to national subsidies supporting large appliances and consumer electronics, with IoT revenue expected to grow by 51% year-on-year to RMB 30.7 billion [3]. - The report notes a significant decline in smartphone shipments in the Indian market, down 38% year-on-year, reflecting Xiaomi's strategic withdrawal from this market due to slowing structural growth [3][4]. Summary by Sections Financial Performance - For Q1 2025, Xiaomi's IoT business is projected to generate RMB 30.7 billion, while smartphone revenue is expected to reach RMB 50.2 billion, reflecting an 8% year-on-year increase [3][13]. - The report forecasts adjusted net profit for Q1 2025 to be around RMB 10.2 billion, with a gross margin of 20.8% for the electric vehicle segment [3][4]. Future Outlook - The report anticipates that the investor day in June and the launch of the YU7 electric vehicle in July will serve as important catalysts for Xiaomi's stock performance [4]. - It is expected that Xiaomi will continue to focus on increasing smartphone prices to navigate potential downturns in global markets, particularly in India and Latin America [4][15]. Earnings Forecast Adjustments - Revenue forecasts for 2025-2027 have been increased by 1%-3% due to rising electric vehicle shipments, with adjusted net profit for 2025 now estimated at RMB 40.1 billion, up from a previous estimate of RMB 34.9 billion [5][14]. - The report also revises the earnings per share (EPS) estimates for 2025 to RMB 1.57, reflecting a 15% increase from earlier projections [8][14]. Valuation - The target valuation multiple has been adjusted from 35.0x to 32.0x based on the 2026 adjusted net profit, reflecting the macroeconomic uncertainties impacting global trade [15][16]. - The report emphasizes that Xiaomi's high-end strategy and the growth of its electric vehicle business are expected to drive future profitability [15][16].

Investment Rating - The report assigns a "Buy" rating to the company with a target price of RMB 146.00, indicating a potential upside of 19% from the current price of RMB 122.75 [1][4][7]. Core Insights - The company reported a revenue growth of 22.4% year-on-year for 2024, reaching RMB 256.7 billion, with Q4 2024 revenue at RMB 68.2 billion, a 13% increase year-on-year [3]. - The CMOS image sensor (CIS) solutions business generated RMB 191.9 billion in revenue for 2024, marking a 23.5% year-on-year growth, driven by high-end smartphone product introductions and automotive CIS business expansion [3][4]. - The smartphone-related CIS revenue reached RMB 98.0 billion in 2024, reflecting a 26.0% year-on-year increase, with plans for new sensor solutions that support high pixel counts and advanced features [3][4]. - The automotive CIS revenue was RMB 59.1 billion in 2024, up 29.9% year-on-year, with expectations for continued growth in 2025-26 due to increased orders from key clients like BYD [4][7]. Financial Summary - The company’s projected financials show a revenue increase from RMB 26.8 billion in 2024 to RMB 32.0 billion in 2025, and further to RMB 37.5 billion in 2026 [6]. - Earnings per share (EPS) are expected to rise from RMB 2.94 in 2024 to RMB 3.84 in 2025, and RMB 4.81 in 2026 [6]. - The price-to-earnings (P/E) ratio is projected to decrease from 33.4 in 2024 to 32.0 in 2025, and further to 25.5 in 2026, indicating improving valuation metrics [6].

Investment Rating - The report maintains a "Buy" rating for JD Logistics with a target price of HK$23.28, indicating a potential upside of 100% from the current price of HK$11.62 [1][2][7]. Core Insights - JD Logistics is expected to benefit from the resilience of the Chinese economy, with a projected revenue growth of 10% year-on-year for Q1 2025, driven by government subsidies for electronic products and home appliances [6][8]. - The company is focusing on automation, self-operated fleet construction, and cost-reduction measures, which are expected to stabilize its net profit margin [6][8]. - Despite the potential negative impact of the US-China trade tensions, JD Logistics has limited direct exposure to international trade, which mitigates the risks associated with tariff increases [6][7]. Financial Summary - Revenue projections for JD Logistics are as follows: RMB 199,540 million for 2025E (+3% from previous estimates) and RMB 216,070 million for 2026E (+4%) [5]. - The expected earnings per share (EPS) for 2025E is RMB 1.18, with a gradual increase to RMB 1.56 by 2027E [2][8]. - The company's financial performance shows a significant increase in net profit from RMB 1,985 million in 2023A to RMB 7,353 million in 2025E [8]. Valuation - The current valuation of JD Logistics is attractive, with a price-to-earnings (P/E) ratio of 9.2x for 2025E, which may decrease further if the acquisition of the remaining 36% stake in Cross-border Express is completed successfully [7][8]. - The report emphasizes that the valuation attractiveness can offset potential negative impacts from external tariff environments [7].

Investment Rating - The report maintains a "Buy" rating for SK Hynix with a target price of KRW 252,569, indicating a potential upside of 39% from the current price of KRW 182,200 [1][6]. Core Insights - In Q1 2025, SK Hynix's DRAM revenue is expected to exceed market expectations with a low single-digit percentage increase quarter-over-quarter, while NAND revenue is anticipated to fall short of expectations with a 20% quarter-over-quarter decline [3][4]. - The report highlights that the demand from Chinese companies for server storage chips is increasing, which may positively impact SK Hynix's DRAM revenue in Q2 2025 [3]. - The NAND business is expected to see a price increase in Q2 2025 due to industry-wide price hikes starting April 1, 2025, despite a projected 20% decline in Q1 2025 revenue [4][6]. Financial Summary - For the fiscal year ending December, the projected financials for SK Hynix are as follows: - Revenue is expected to grow from KRW 32,766 billion in 2023 to KRW 82,685 billion in 2025, and further to KRW 108,000 billion by 2027 [5]. - Earnings per share (EPS) are projected to improve from a loss of KRW 13,281 in 2023 to a profit of KRW 37,696 in 2025 [5]. - The price-to-earnings (P/E) ratio is expected to decrease from 6.3 in 2024 to 4.7 in 2026, indicating a potentially undervalued stock [5].

Investment Rating - The report maintains a "Buy" rating for Gushengtang (2273 HK) with a target price of HK$61.84, indicating a potential upside of +117% from the current price of HK$28.55 [3][9][19]. Core Insights - Gushengtang has shown robust growth in its healthcare solutions, with total revenue for 2024 reaching RMB 3.022 billion, a year-on-year increase of 30.1%, and net profit of RMB 307 million, up 21.4% [7][13]. - The company is expanding its international presence, having entered the Singapore market, which contributed RMB 31.52 million to its revenue [8]. - The report projects revenue and net profit growth rates for 2025E-2027E at 26%/23%/19% and 26%/24%/18%, respectively [7][15]. Financial Summary - Revenue for 2025E is projected at RMB 3.819 billion, with a gross profit of RMB 1.150 billion and a net profit of RMB 386 million [13][24]. - The earnings per share (EPS) for 2025E is estimated at RMB 1.61, with a P/E ratio of 16.1, which is lower than the industry average of 27x [3][19][21]. - The company’s gross margin is expected to remain stable at around 30% to 31% through 2027E [8][19]. Adjustments and Forecasts - The target price has been adjusted down from HK$73.95 to HK$61.84, reflecting a 16% decrease due to revised earnings forecasts [3][19]. - The report has lowered the 2025E and 2026E EPS estimates by 19% and 24%, respectively, due to anticipated costs associated with digital transformation and expansion efforts [15][17]. Valuation - The DCF valuation method indicates a target price of HK$61.84, corresponding to a P/E of 35x for 2025, suggesting a premium valuation due to the company's unique position in the TCM service market [19][20].

Investment Rating - The report initiates coverage with a "Buy" rating for the company, with a target price of RMB 194.39, indicating a potential upside of 54% from the current price of RMB 126.54 [1][6][26]. Core Insights - The company is positioned to benefit from a comprehensive product line in medical imaging, challenging the dominance of imported brands in the Chinese market. The product lines include CT, MR, XR, MI, and RT, with significant market shares in previously monopolized segments [6][20][40]. - The company is expected to experience a revenue CAGR of 14.2% from 2023 to 2026, driven by technological advancements and policy support, despite facing short-term impacts in 2024 [6][22][24]. - The overseas business has shown strong growth, with revenue reaching RMB 9.33 billion in the first half of 2024, a 29.9% increase year-on-year, indicating the company's expanding international influence [7][23]. - The report highlights the company's focus on R&D innovation, with significant investments leading to the launch of groundbreaking products, such as the world's first 5T whole-body clinical MR [24][25]. Financial Summary - The company's revenue is projected to grow from RMB 10.26 billion in 2024 to RMB 16.98 billion in 2026, with net profit expected to rise from RMB 1.26 billion to RMB 2.88 billion during the same period [8][22]. - The earnings per share (EPS) estimates for 2024, 2025, and 2026 are RMB 1.52, RMB 2.62, and RMB 3.50, respectively, reflecting a positive growth trajectory [2][8]. Market Context - The Chinese medical imaging equipment market is projected to grow at a CAGR of 10.9% from 2019 to 2023, with the CT segment holding the largest market share at 32% in 2023 [29][30]. - The report emphasizes the increasing demand for high-end medical imaging equipment driven by an aging population and rising health awareness, which is expected to sustain market growth [33][34].

Investment Rating - The report maintains a "Hold" rating for Kingdee International (268 HK) with a target price of HK$14.94, indicating a potential downside of 1% from the current price of HK$15.14 [1][8]. Core Views - The report highlights that Kingdee's stock price has increased by 94% year-to-date, outperforming the Hang Seng Index, which rose by 23%. However, the company's fundamental recovery is lagging behind this valuation increase [6]. - For the second half of 2024, Kingdee's revenue grew by 9% year-on-year to RMB 3.39 billion, which was below market expectations. The annual recurring revenue (ARR) increased by 20% to RMB 3.43 billion, also falling short of expectations [6][10]. - The report notes that Kingdee's cloud service revenue grew by 10% year-on-year to RMB 2.72 billion, again below market consensus [6][10]. - The management expects ARR to grow by approximately 20% in 2025, with revenue growth anticipated to accelerate to 14% year-on-year [6][10]. Summary by Sections Investment Rating and Price Target - The target price has been raised from HK$6.38 to HK$14.94, reflecting a significant increase of 134% [2][12]. - The current valuation is aligned with global peers, with a projected P/S ratio of 7.0, up from 2.8 [8][12]. Financial Performance - For 2025, the expected revenue is RMB 7.15 billion, with a year-on-year growth of 14% [9][10]. - The report projects a net profit of RMB 176 million for 2025, with an EPS of RMB 0.05 [9][10]. - The operating profit is expected to reach RMB 75 million in 2025, indicating a return to profitability [9][10]. Adjustments and Forecasts - Due to underperformance in the second half of 2024, revenue forecasts for 2025 and 2026 have been adjusted downwards by 3% and 5%, respectively [7][10]. - The ARR forecast for 2025 has been revised to a growth of 22%, down from previous estimates [7][10]. Market Comparison - Kingdee's market capitalization is approximately US$6.99 billion, with a three-month average daily trading volume of US$89 million [1][12]. - The report compares Kingdee's performance with global peers like SAP and Workday, noting that Kingdee's revenue growth and AI monetization capabilities are still developing [8][12].